Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. ICA Health, LLC/Future Formulations, LLC
WARNING LETTER
•ICA Health, LLC/Future Formulations, LLC•September 20, 2021

FDA WARNING_LETTER - ICA Health, LLC/Future Formulations, LLC - September 20, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

The FDA issued a Warning Letter to Dr. Wilson regarding products sold on www.icahealth.com, www.drwilsons.com, and www.adrenalfatigue.org. The FDA reviewed these websites in July 2021 and determined that Dr. Wilson’s Good Sugar, Dr. Wilson’s Super Immune Space Sprinkles, Dr. Wilson’s Cortisol Stress Reset, Dr. Wilson’s BFF, and Dr. Wilson’s Nat-Stim are unapproved new drugs and misbranded drugs under the Federal Food, Drug, and Cosmetic Act.

The products are deemed drugs because website claims establish their intent for use in the cure, mitigation, treatment, or prevention of diseases, including metabolic syndrome, diabetes, cardiovascular disease, anxiety, mood disorders, cognitive impairment, sleep problems, inflammation, depression, high cholesterol, high blood pressure, heart attack, stroke, pain, decreased immune function, alcoholism, addiction, autoimmune inflammatory reactions, bronchitis, pneumonia, respiratory infections, dental problems, fibromyalgia, herpes, hypoglycemia, rheumatoid arthritis, and the common cold.

These products are considered "new drugs" under section 201(p) of the Act [21 U.S.C. 321(p)] because they are not generally recognized as safe and effective for their stated uses and lack prior FDA approval. Introducing or delivering them into interstate commerce without approval violates sections 301(d) and

Company
ICA Health, LLC/Future Formulations, LLC
Inspection Date
September 20, 2021
Product Type
Food
Office
Office of Human and Animal Foods Operations – Division West 4
Person
  • Mark Harris (E.)
Open in Dashboard

ID · e98a5e55-70f7-411e-8680-1e32343ec225

Violation Codes8
21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)21 U.S.C. 331(a)

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026, Global Key Solutions All rights reserved.